Results: 13

Obstacles in combating multidrug resistant tuberculosis in pediatric patients: a scope review

Abstract Objectives: to identify the scientific evidence on excessively resistant and multidrug resistant tuberculosis in pediatric patients. Methods: this is a scope review of the literature, with a guiding question: "What is the scientific evidence on multidrug-resistant tuberculosis (MDR-TB) and ext...

Factores asociados a tuberculosis pre extensamente resistente en pacientes del Hospital Nacional Dos de Mayo, Lima, Perú

Rev. chil. infectol; 40 (5), 2023
INTRODUCCIÓN: La resistencia a fármacos antituberculosos está influenciada por las características personales y las condiciones de salud de países en vías de desarrollo. OBJETIVO: Determinar los factores asociados a TB-pre extensamente resistente (TB-PRE XDR) en pacientes del Hospital Nacional Dos ...

Clinical and epidemiological features of tuberculosis isolated from critically ill patients

Rev. argent. microbiol; 54 (1), 2022
Human tuberculosis is still a major world health concern. In Uruguay, contrary to the world trend, an increase in cases has been observed since 2006. Although the incidence of MDR-resistant strains is low and no cases of XDR-TB were registered, an increase in the number of patients with severe tuberculos...

Impacto da implantação do teste rápido molecular para a tuberculose no Brasil

Introdução: A tuberculose (TB) ainda se apresenta como um grave problema de saúde pública no mundo, com mais de 10 milhões de casos e 1,3 milhão de mortes anualmente. Em 2020, no Brasil, foram notificados 66.819 casos novos de TB, e aproximadamente 913 casos de TB drogarresistente. Cerca de 4.500 p...

Tuberculose multirresistente: análise epidemiológica em um hospital de ensino

Objetivo: Descrever o perfil epidemiológico dos pacientes diagnosticados com Tuberculose Multirresistente em um hospital de ensino de referência na cidade do Rio de Janeiro. Método: Estudo descritivo, quantitativo, desenvolvido em uma instituição terciária de ensino de referência para tratamento d...

Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis

Biomédica (Bogotá); 40 (4), 2020
Abstract . Introduction: Multidrug-resistant tuberculosis treatment is effective in 50% of patients due to several factors including antibiotic susceptibility of the microorganism, adverse treatment reactions, social factors, and associated comorbidities. Objectives: In this study, we describe the demog...

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil

Mem. Inst. Oswaldo Cruz; 115 (), 2020
BACKGROUND Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis, and the number of new cases of multidrug resistant TB (MDR-TB), pre extensively drug-resistant TB (pre-XDR-TB) and extensively drug-resistant TB (XDR-TB) has increased considerably worldwide. OBJEC...

Serie de casos: tuberculosis extremadamente resistente a drogas en Colombia, 2006-2016

Biomédica (Bogotá); 39 (4), 2019
Introducción. La tuberculosis extremadamente resistente a los medicamentos (TB-XDR) es el resultado de deficiencias en la administración del tratamiento y en la prevención de la transmisión de la enfermedad; además, es un reto para los programas nacionales de control de la tuberculosis. Objetivo. De...

Tuberculosis congénita pre-extensivamente resistente a drogas: reporte de caso

RESUMEN La tuberculosis en el lactante es un cuadro de difícil diagnóstico por las pruebas diagnósticas que muchas veces resultan negativas y por la dificultad de identificar la fuente de transmisión. Se presenta el caso de un lactante varón de un mes de vida que presenta irritabilidad, taquipnea, f...

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

J. bras. pneumol; 44 (2), 2018
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) continue to represent a challenge for clinicians and public health authorities. Unfortunately, although there have been encouraging reports of higher success rates, the overall rate of favorable out...